We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Neil Woodford just snapped up a bargain stock you’ve probably never heard of

Neil Woodford’s new stock buy could be a great addition to your portfolio, says G A Chester.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Renowned fund manager Neil Woodford is well known for his big investments in blue-chip companies. FTSE 100 giants in the pharma and tobacco sectors — AstraZeneca, Imperial Brands, British American Tobacco and GlaxoSmithKline — are the top holdings in his flagship equity income fund.

However, he’s certainly not averse to looking for stocks outside the mega-caps. Indeed, the market was notified this week that he’s bought a £70m stake in a business that many readers have probably never heard of. The company in question only joined the stock market this time last year and is listed in the FTSE SmallCap index.

Should you buy Forterra Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

However, like Woodford, I’m not put off by this. The company has a long trading history (it was the building products division of conglomerate Hanson back in the day) and it’s a decent size, with a market cap of about £450m. Furthermore, it looks to be a bargain buy.

A big show of confidence

Forterra (LSE: FORT) announced this week that Woodford has taken a notifiable stake in the company. In one day’s dealing last Friday his holding crossed the disclosable thresholds of 5%, 10%, 11%, 12%, 13%, 14%, 15% and 16%. By the end of the day, he owned over 33m shares — 16.7% of Forterra.

Woodford’s £70m investment is a big show of confidence in one of the leading manufacturers of building products for the UK building and construction industry. It follows Forterra’s maiden annual results as a listed company, which were released last month. The results were in line with expectations and management said that “2017 has started well, building on the momentum seen in the second half of 2016”.

The City consensus earnings forecast for the current year is for growth of 8%, taking earnings per share (EPS) to 23.2p, giving a price-to-earnings (P/E) ratio of 9.9 at a share price of 230p. The P/E is below the value threshold of 10 and a further advance in EPS forecast for next year drops it to 9. Meanwhile, a prospective dividend yield of 3.9%, rising to 4.3%, only adds to the stock’s value credentials.

Branded business parks

While Forterra is a new investment for Woodford, Sirius Real Estate (LSE: DRX) is an existing holding that he’s just pumped more cash into. This leading operator of branded business parks in Germany has a similar market cap to Forterra, being £470m at a share price of 53.5p.

Sirius notified the market this week that Woodford has increased his holding in the company from 38.3m shares to 44.9m. The purchase gives him a 5.1% stake valued at £24m, and follows a trading statement from the company earlier this month ahead of annual results scheduled for late June.

Sirius said the results are set to be in line with expectations. The City consensus is for EPS of 3.75p, giving a P/E of 14.3, which falls to 12.9 next year on forecasts of 11% EPS growth. The rating is rather higher than Forterra’s — but still reasonable — and the trade-off is that Sirius has a higher prospective yield of 4.8%, rising to 5.2%.

I can see why Woodford’s keen on both stocks and their valuations suggest now could be a good time to buy them.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

How to buy growth stocks at below-market prices

Don’t want to pay market prices for growth stocks? Here's a sneaky strategy investors can use to get deals at…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Are Meta shares at the start of a comeback?

Shares in Meta Platforms have been held back by the firm’s high-risk approach to AI. But is this the moment…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

With dividend yields averaging above 7%, are these 2 UK shares worth considering?

Muhammad Cheema looks at two UK shares: ITV and Legal & General. With yields of 6.1% and 8.1%, should investors…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

How much do you need to invest in dividend stocks to be able to retire?

Some 77% of people in the UK won't have enough income to manage a moderate retirement. Here’s how dividend stocks…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

FTSE 250 stock CMC’s shares have rocketed 51%! What’s going on?

CMC Markets' shares have surged by double-digits today after a strong full-year trading update. Is the FTSE 250 company now…

Read more »

A row of satellite radars at night
Investing Articles

Will I buy SpaceX at £100 a share in my SIPP?

Ben McPoland is considering adding SpaceX stock to his SIPP on 12 June. Might this be a no-brainer buy-and-hold opportunity?

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Aberdeen shares are back in the FTSE 100 — is this turnaround stock just getting started?

Following its return to the FTSE 100, Andrew Mackie examines whether Aberdeen's shares could be on the cusp of a…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Down 65% with a 5.65% yield! Is this dividend share a once-in-a-decade buy? 

Harvey Jones says this dividend share is still posting decent profits at a challenging time. Its low valuation and high…

Read more »